XLO vs XRAY · rev $31.3M vs rev $1.78B
Xilio Development Inc (XLO) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
XLO currently screens at market cap $55.3M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the XLO and XRAY stock pages for the full models.
Not investment advice.